1.1: pyridinium chlorochromate / ethyl acetate / 3.5 h / 20 - 25 °C 1.2: 6 h / 45 - 50 °C / 2585.81 Torr 2.1: lithium tri-t-butoxyaluminum hydride / tetrahydrofuran / 5 h / 5 - 10 °C 3.1: water; sodium hydroxide / methanol; tetrahydrofuran / 4 h / 0 - 35 °C View Scheme
参考文献
Kythera Biopharmaceuticals ,Inc.; Moriarty, Robert M.; Prasad, Achampeta Rathan; Reid, John Gregory; Swaringen, JR., Roy A.
Patent: US2013/137884 A1, 2013 ;
